跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 30 条关于
“Sephience (sepiapterin)”
全部
30
临床试验
4
药物
4
机构
1
资讯
21
25天前
PTC Therapeutics' Sephience (sepiapterin) Data Reinforce Broad PKU Benefits, Including Diet Liberalization and Sustained Metabolic Control
去年
PTC Therapeutics' Sephience Receives Positive CHMP Opinion for Phenylketonuria Treatment Across All Age Groups
9个月前
PTC Therapeutics Secures Global Approvals for Sephience in PKU Treatment Across Canada and Japan
2个月前
PTC Therapeutics Launches Sephience for PKU with $125M in Q1 Sales and $500M Convertible Note Offering
去年
FDA Accepts PTC Therapeutics' NDA for Sepiapterin to Treat PKU
2年前
FDA Accepts PTC Therapeutics' NDA for Sepiapterin to Treat PKU
去年
FDA Accepts NDA for PTC Therapeutics' Sepiapterin in Phenylketonuria Treatment
11个月前
uniQure's Huntington's Disease Gene Therapy Shows 75% Reduction in Disease Progression, Pressures PTC Therapeutics
去年
PTC Therapeutics Announces Key Clinical and Regulatory Milestones for 2025
去年
FDA Sets Q3 2025 Approval Dates for Three Breakthrough Therapies Targeting Rare Diseases
第 1 页,共 3 页
上一页
下一页